
Advertise on podcast: Purple Pen Podcast
Rating
5from
This podcast has
201 episodes
Language
EnglishPublisher
Purple Pen PodcastExplicit
No
Date created
2016/10/28
Latest episode
2026/11/07
Average duration
40 min.
Release period
18 days
Description
Education and news for pharmacists, with a focus on Australian clinical pharmacy practice. Hosted by Kristin Xenos and Natalie Tasker, we provide CPD and news for pharmacists, especially those interested in Australian clinical practice. Created by Jane Booth and Dan Guidone.
Unlock Purple Pen Podcast podcast Email contact info,
Listeners & Audience details
Email contact information
Direct podcast contact details

Listeners
Audience numbers & engagement insights

Audience details
Podcast Insights

Social media
Check Purple Pen Podcast social media presence
Podcast episodes
Check latest episodes from Purple Pen Podcast podcast
PPP201 - Mind the Gap: Cavities, Myths and Oral Health with Professor Ian Meyers and Geraldine Moses
2026/11/07
Join Professor Ian Meyers and Dr Geraldine Moses as they separate oral health fact from fiction in an engaging discussion on fluoride myths, dry mouth, toothpastes, and the products lining our pharmacy shelves. From why drinking more water may not be the only answer to managing xerostomia to the differences between stannous and sodium fluoride, they unpack the evidence behind everyday oral health advice.
The conversation also explores the role of Tooth Mousse and other calcium-based products, whether toothpaste additives are worth the hype, whether clove oil still has a place in oral care, and the evidence for teething gels. With practical insights for older adults, children, cancer patients, and those with orthodontic appliances, this episode is packed with expert tips to help clinicians and consumers make informed oral health decisions.
PPP 200 - Beyond Eye Pressure: A New Lens on Glaucoma with Prof Andrew White
2026/11/01
In this episode, Kristin speaks with Professor Andrew White, ophthalmologist at Westmead Hospital and Head of the Centre for Vision Research, about how our understanding of glaucoma has evolved and why reducing the condition to an issue of eye pressure can oversimplify a complex neurodegenerative disease. Together they explore the relationship between intraocular pressure, optic nerve damage and visual loss, challenging long-held assumptions about diagnosis, risk and disease progression. The conversation examines why glaucoma continues to threaten sight without warning, and what clinicians and patients need to understand about its often subtle presentation.
Drawing on both clinical experience and emerging evidence, Professor White reflects on the changing landscape of glaucoma care, from contemporary models of diagnosis and collaborative management to the strengths and limitations of current treatment approaches. He discusses the implications of landmark research, the growing role of laser therapies, and the ongoing shift toward more personalised and proactive care. The episode offers a thoughtful look at where glaucoma management stands today and where the next decade of innovation may lead.
More reading and resources:
https://iovs.arvojournals.org/article.aspx?articleid=2812642
https://eyewiki.org/Clinical_Trials_in_Glaucoma
https://brienholdenfoundation.org/wp-content/uploads/2026/03/AEEHS_Summary_report.pdf
https://www.sciencedirect.com/science/article/pii/S2214109X26001051
https://pubmed.ncbi.nlm.nih.gov/9544649/
https://pubmed.ncbi.nlm.nih.gov/9544649/
Recommendations | Glaucoma: diagnosis and management | Guidance | NICE
Seonix Bio | SightScore™ | Using Genetics to Predict Glaucoma Risk
PPP 199 - Celebrating 10 Years of the Purple Pen Podcast
2026/10/29
To celebrate a full decade on air, current hosts Kristin Xenos and Natalie Tasker are joined by the podcast's original hosts and creators, Jane Booth and Dan Guidone, for a special bonus episode.
Together, the four of them look back at where it all began — the origins of Purple Pen Podcast, the philosophies that have shaped it over the years, and some of their favourite highlights along the way.
Whether you've been with us since episode one or have just found the show, this is a fun, nostalgic look at how Purple Pen Podcast came to be — and where it's headed next.
In this episode:
How Jane and Dan first came up with the idea for the podcast
The show's founding philosophy and how it's evolved
Memorable moments and favorite episodes from the past 10 years
Thank you for ten incredible years — here's to many more!
PPP 198 - Pins, Needles, and Too Much Vitamin B6 with Angus Thompson
2026/10/17
In this episode we celebrate our ten‑year podcast anniversary with guest Angus Thompson, a consulting clinical pharmacist and clinical editor who works across Southern Tasmania. We open with a quick roll call of the B‑group vitamins to set the scene before shifting into the main focus of the conversation: how Vitamin B6 became a ubiquitous ingredient in sleep products, menopause supplements, energy blends, magnesium powders and everyday multivitamins.
Angus explains why B6 deficiency is relatively uncommon, why it still appears in so many products, and how recommended daily intakes are exceeded in many supplements. We discuss what B6 is actually indicated for, the most common forms found in supplements, and why assumptions about "water‑soluble vitamins being harmless" have not held up in practice. The heart of the episode looks at B6 toxicity and its link to peripheral neuropathy, what symptoms clinicians should look for, how it's diagnosed, potential for long term harm, and why many patients don't realise their supplements could be contributing.
We also talk through the TGA's strengthened safety controls announced in November 2025 and whether recent media coverage has helped or confused the public conversation.
Further information can be found here:
Stronger safety controls to be introduced for products containing vitamin B6: https://www.tga.gov.au/news/media-releases/stronger-safety-controls-be-introduced-products-containing-vitamin-b6
Scientific opinion on the tolerable upper intake level for vitamin B6: https://efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2023.8006
Peripheral Neuropathy - A Review: https://jamanetwork.com/journals/jama/fullarticle/2841552
Australian and New Zealand Nutrient Reference values: https://www.eatforhealth.gov.au/nutrient-reference-values/nutrients/vitamin-b6
Vitamin B6 Fact Sheet for Health Professionals: https://ods.od.nih.gov/factsheets/VitaminB6-HealthProfessional/
https://www1.racgp.org.au/ajgp/2025/august/pyridoxine-toxicity-from-over-the-counter-suppleme
PPP 197 - The Point of Injection with Anna Theophilos
2026/09/24
In this episode, Kristin sits down with Melbourne-based community pharmacist Anna Theophilos, the Pharmaceutical Society of Australia's inaugural Vaccination Ambassador, for a deep dive into the world of pharmacist-led injectable medicines administration.
Anna brings her expertise on everything from injection technique to patient hesitancy, offering practical insight for pharmacists looking to build confidence and consistency in this growing area of practice.
In this episode, Kristin and Anna discuss:
The role of pharmacists and the pharmacy workforce in facilitating injectable medicines administration — whether that's giving injections directly or supporting patients to safely self-administer
Where the current gaps are, and what the safety data actually tells us
Addressing vaccine hesitancy and the pharmacist's role in administering vaccines and other injectables
Making the most of opportunistic travel health consultations, including on-the-spot vaccination
Demystifying injection technique and equipment selection — getting the medicine where it needs to go for the patient in front of you
Supporting patients before and after administration
The opportunity to create a more consistent vaccination experience across pharmacies nationwide
Managing and preventing vaccine administration-related adverse effects
Navigating vaccination schedules and planning for multiple vaccines on the same day, plus reliable (and reassuring) sources of information
Approaching challenging conversations around safe injectable use by staying patient-centred, curious, and non-judgemental
Connect with Anna:
Follow Anna on Instagram: @thevaccinationpharmacist
PPP 196 - Long-acting injectable buprenorphine (LAIB) with Conjoint Professor Nicholas Lintzeris
2026/09/12
In this episode, Professor Nicholas Lintzeris joins us to discuss where LAIB fits in contemporary opioid dependence treatment, how it compares with methadone and sublingual buprenorphine, and which patients are most likely to benefit. We also explore practical aspects of initiation, dosing, administration, management of adverse effects, and common misconceptions surrounding depot buprenorphine therapy.
Sublocade, will be removed from Australian markets at the end of 2026 . Made by US-based pharmaceutical company Indivior, the medication is one of two long-acting, slow-release buprenorphine injections on the Pharmaceutical Benefits Scheme (PBS) for opioid dependence treatment. Buvidal, remains available on the PBS.
Further reading and resources
https://theconversation.com/buvidal-is-it-really-a-game-changer-in-the-treatment-of-problematic-opioid-use-214895
NSW Guideline - https://www.health.nsw.gov.au/aod/resources/Pages/laib.aspx
PPP 195 - Otitis Media with Dr Evan Tseros
2026/08/15
In this episode, Dr Evan Tseros, Otolaryngologist, Head & Neck Surgeon, joins us to discuss the different types of otitis media, how to distinguish it from conditions such as otitis externa and eustachian tube dysfunction, and the assessment of otalgia, including important causes of referred ear pain. We also explore current management recommendations, the role of antibiotics, key red flags, and practical safety-netting advice for pharmacists.
Further reading and resources:
Royal Children's Hospital https://www.rch.org.au/clinicalguide/guideline_index/acute_otitis_media/
Clinical Practice Guideline: Otitis Media with Effusion (Update) - American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS)
https://dontforgetthebubbles.com/otitis-media/
PPP 194 – Sport and Exercise Pharmacy with Alison Hooper
2026/07/11
PPP 194 – Sport and Exercise Pharmacy with Alison Hooper
In this episode, pharmacist and former physiotherapist Alison Hooper joins us to discuss the expanding role of pharmacists in sport, exercise, and active living
We cover:
How pharmacists can support movement, exercise, and sport Injury management and common sports-related conditions Managing chronic conditions in active people Exercise-induced asthma Therapeutic Use Exemptions (TUEs) WADA and anti-doping regulations Accidental doping risks from supplements RICER vs PEACE & LOVE for injury management The latest evidence on NSAIDs in sport Whether you're working with elite athletes or helping patients stay active, this episode highlights the important role pharmacists play in supporting safe participation in sport and exercise.
Further Reading and Resources Links
Understanding pharmacists' engagement in sport and exercise medicine, including pharmacist-physiotherapist collaboration: A qualitative study and COM-B analysis. https://www.sciencedirect.com/science/article/pii/S2667276625000344 WADA website: Raising the game for clean sport | World Anti Doping Agency WADA Prohibited List: 2025list_en_final_clean_12_september_2024.pdf Sport Integrity Australia: Protecting Sport Together | Sport Integrity Australia Sports Integrity Australia Sports Pharmacy eLearning Course: New Sports Pharmacy eLearning Course Launched Global Drug Reference Online: Global DRO - Home Sports Integrity Australia 'Check Your Substances' (links to Global DRO) Check Substances On Global DRO | Sport Integrity Australia Informed Sport (Supplement Batch Testing): Sports Supplements Certification | Informed Sport HASTA (Supplement Certification and Testing): Home - HASTA US Sports Pharmacy Group: U.S. Sports Pharmacy Group Sports Pharmacy Network: Sports Pharmacy Network
PPP 193 - Childhood Cancer in First Nations People with Dr Jessica Buck
2026/07/05
To align with NAIDOC week this year we have a special bonus episode.
In this episode, we speak with Dr Jessica Buck about childhood cancer in First Nations people, genomics, and the importance of cultural safety in healthcare and research. A proud Kamilaroi woman, she is the Team Leader of the First Nations Childhood Cancer Program at The Kids Research Institute Australia — a first-of-its-kind initiative dedicated to developing culturally safe, community-led research strategies to improve outcomes for First Nations children with cancer.
Together, we explore how a First Nations perspective can strengthen biomedical science and improve care for Aboriginal and Torres Strait Islander children and families affected by cancer.
We cover:
What culturally safe healthcare and research look like in practice
Applying a First Nations lens to genomics and biomedical science
How historical harms in healthcare and research continue to influence trust today
Childhood cancer outcomes for First Nations children
The impact of geography, access to care, racism and broader inequities
Why representation in genomic databases and clinical trials matters
The clinical implications of underrepresentation for diagnosis and treatment
The potential role of pharmacogenomics in cancer care
Treatment-related adverse effects
Opportunities to improve equity in childhood cancer care
Further reading and resources:
Clark (Adnyamathanha), J.R., Buck (Kamilaroi), J., Richards-Satour (Adnyamathanha and Barngarla), A., Lyons (Jaadwa), L. and Brown (Yuin), A. (2024), Towards precision cancer medicine for Aboriginal and Torres Strait Islander cancer health equity. Med J Aust, 221: 68-73. https://doi.org/10.5694/mja2.52346 https://onlinelibrary.wiley.com/doi/10.5694/mja2.52346
Alexandra Truong, Kayla Williams‐Tucker (Ngarluma, Wongutha, Wudjari Noongar), Ahmi Narkle (Whadjuk Goreng Noongar), Eden Slicer (Gundungurra), Jessica‐Elise Chapman (Kamilaroi, Bundjalung), Jessica Lawler, Rishi S Kotecha, Hetal Dholaria, Justine R Clark (Adnyamathanha), Alex Brown (Yuin), Raelene Endersby, Nicholas G Gottardo and Jessica Buck (Kamilaroi) - Current gaps in knowledge and future research directions for Aboriginal and Torres Strait Islander children with cancer - https://www.mja.com.au/journal/2025/222/10/current-gaps-knowledge-and-future-research-directions-aboriginal-and-torres
The Kids Research Institute Australia https://www.thekids.org.au/our-research/chronic-diseases/first-nations-childhood-cancer/
Zero Childhood Cancer https://www.zerochildhoodcancer.org.au/
Henrietta Lacks: science must right a historical wrong - https://www.nature.com/articles/d41586-020-02494-z
A note on the artwork for this episode: "Cancer 2025"
Shaznaye Bin-Kali, is a Kija and Yawuru Jij from Broome, W.A. She is 15 years old. She was diagnosed with brain cancer at six months old and experienced her first seizure at the age of one, which led to her first operation. This painting represents the spread of her brain cancer. The lines surrounding it symbolise her very first seizure, an important moment in my journey. Through her art, she shares her story, resilience, and connection to her culture.
Note: NAIDOC stands for the National Aborigines and Islanders Day Observance Committee. It aims to celebrate and recognise the history, culture and achievements of Aboriginal and Torres Strait Islander peoples.
PPP 192 - Colonoscopy with Dr Kostas Brooks
2026/06/16
Gastroenterologist and three-time guest Dr Kostas Brooks returns for a discussion on colonoscopy, bowel cancer screening, and best practice care in Australia.
In this episode, we cover:
Home bowel cancer screening
The role of home-based faecal occult blood tests in early detection
How the program works in practice
What best practice looks like in screening and surveillance
Bowel preparation for colonoscopy
Why there is no single standard bowel preparation protocol
Practical tips to support patients to achieve optimal preparation
Key considerations for medicines before and after colonoscopy
What happens during a colonoscopy
Step-by-step overview of the procedure
Emerging role of artificial intelligence in detection and diagnosis
Colorectal cancer in Australia
Prevalence and key risk factors
Who is most at risk and why
What happens next after a positive colonoscopy finding
Further reading
Australian Commission on Safety and Quality in Health Care - Colonoscopy Clinical Care Standard - https://www.safetyandquality.gov.au/clinical-care-standards/colonoscopy
National Bowel Cancer Screening Program - https://www.health.gov.au/our-work/national-bowel-cancer-screening-program?language=en
Bowel Cancer Australia - Red Apple Day - https://redappleday.au/
PPP 191 - Slowing Myopia Progression: How Atropine Fits in with Dr Loren Rose
2026/06/13
In this episode of Myopia Progression and the Role of Atropine in Managing Myopia, we speak with Dr Loren Rose about one of the fastest growing challenges in children's eye health. We explore emmetropisation, the natural process by which a child's eyes develop towards clear vision, and what happens myopia. Dr Rose explains key concepts including hyperopic reserve, what a dioptre actually measures, and why both genetics and environment play important roles in myopia development. We discuss the influential Taiwan studies showing that spending around two hours outdoors each day can help reduce the risk of myopia, as well as the evidence linking prolonged near work and screen use with increasing rates of short-sightedness. We discuss the role of atropine drops and peripheral defocus lenses.
Further reading
Rose LVT. The quest for safe and effective myopia control in children. Clin Exp Ophthalmol. 2024 Jul;52(5):503-504. doi: 10.1111/ceo.14391. PMID: 38950909. - https://pubmed.ncbi.nlm.nih.gov/38950909/ Optometry Australia Position Statement on Myopia Management - https://www.optometry.org.au/wp-content/uploads/Professional_support/Guidelines/Myopia-Position-Statement-2024-v3.pdf https://www.optometry.org.au/wp-content/uploads/2025/Documents/Myopia-management-resource-guide.pdf
PPP 190 - Osteoporosis with Dr Mariya Farah Kitson
2026/05/16
In this episode, we're joined by Dr Mariya Farah Kitson, Consultant Rheumatologist at the Osteoporosis Refracture Prevention Clinic at Royal North Shore Hospital, for a deep dive into the diagnosis and management of osteoporosis. We explore why osteoporosis remains significantly underdiagnosed, current recommendations for bone mineral density (BMD) screening, and the ongoing osteoporosis care gap that leaves many patients untreated after fragility fractures. Dr Kitson also explains the role of secondary fracture prevention services and why menopause represents a particularly high-risk period for accelerated bone loss and fracture risk in women.
The conversation also unpacks the evolving treatment landscape for osteoporosis, including discussions around denosumab, its PBS and other indications, and important considerations regarding duration of therapy and rebound vertebral fracture risk following discontinuation. Dr Kitson compares the mechanisms of action of denosumab and bisphosphonates, outlines current recommendations for safely stopping denosumab, and discusses where newer therapies such as romosozumab fit into contemporary osteoporosis care. We also touch on the emerging role of biomarkers in fracture risk assessment and treatment monitoring, offering listeners an up-to-date and clinically relevant overview of osteoporosis management.
Further Links
ASBMR - The American Society for Bone and Mineral Research - https://www.asbmr.org/Default.aspx
International Osteoporosis Foundation https://www.osteoporosis.foundation/
PPP 189 - Scabies with Dr Francis Lai
2026/04/11
In this episode, dermatologist Dr Francis Lai joins us to unpack everything you need to know about scabies — what it is, how it spreads and why some communities are more at risk. We break down diagnosis, treatment options, common myths and what to expect during recovery. Practical, evidence‑based advice for clinicians, parents and anyone dealing with this incredibly itchy but entirely treatable condition.
PPP 188 - Menopause Part 2 with Jarrah Anderson and Bo Youn Kim
2026/03/14
Kristin speaks with two pharmacists working in menopause care:
Bo Kim, clinical pharmacist and founder of EmpowHer Menopause in Perth
Jarrah Anderson, Clinical Lead at MedCast and member of the Quality Use of Medicines Alliance
In this episode Types of menopausal hormone treatment (MHT)
When different MHT options are used in perimenopause and menopause.
Safety conversations
Current thinking on precautions and contraindications, and how to explain risks and benefits clearly.
Access and cost in Australia
PBS considerations, affordability and opportunities for pharmacist support.
Bio‑identical and body‑identical hormones
Why it matters for patient communication.
Testosterone in menopause care
What the evidence says about when it can be used and practical issues with prescribing and access.
Non‑hormonal therapies Options for symptom management, including the emerging medicine fezolinetant.
Links:
Medcast
Qhub - quality use of medicines resources - https://medcast.com.au/qhub
Australian Menopause Society
Complementary medicines and therapies: options for menopausal symptoms - https://hub.menopause.org.au/Play?pId=3234710f-e5db-4aa1-bff8-ae98449fffad
Guide to MHT/HRT Doses - https://hub.menopause.org.au/Play?pId=6ecead60-db26-4dfc-a662-794d7b39ef59
Jean Hailes
Perimenopause and menopause symptom checklist
https://jeanhailes.org.au/wp-content/uploads/2026/01/Perimenopause-and-menopause-symptom-checklist_TGD.pdf
PPP 187 - Menopause Part 1 with Prof Susan Davis
2026/03/07
This International Women's Day (IWD) we a focused on women's health. In this episode, Kristin speaks with Professor Susan Davis, AO, MBBS, FRACP, PhD, FAHMS, Head Monash University Women's Health Research Program, Endocrinologist, leading menopause researcher. Prof Davis is Director of the Women's Health Research Program in the School of Public Health and Preventive Medicine, Monash University Melbourne. She is a consultant Endocrinologist at Cabrini Medical Centre and Head of the Women's Specialist Clinic, the Alfred Hospital Melbourne. She is also President of the International Menopause Society and Past-President of the Australasian Menopause Society.
They discuss the definitions of menopause, the menopause transition and perimenopause, along with factors that influence the timing of menopause and the wide range of symptoms women may experience.
Professor Davis explains the role of blood hormone testing in menopause care. The conversation also covers contraception in perimenopausal women. They also review the evidence for menopausal hormone therapy, including indications for treatment, the benefits and risks of different therapies, and duration of use.
Links:
https://www.menopause.org.au/
Podcast reviews
Read Purple Pen Podcast podcast reviews
Difficult scheduler 2017/06/08
Great Pharmacology Podcast
I'm an emergency physician and medical toxicologist (not a pharmacist) in the U.S. and I've really enjoyed this podcast. Some of the guests I recogniz...
Podcast sponsorship advertising
Start advertising on Purple Pen Podcast relevant audience podcasts
You may also like to advertise on these Podcasts

4.116068469
The Tucker Carlson Show
Tucker Carlson Network

4.828110458
Huberman Lab
Scicomm Media

4.240683
To Be The Man
Podcast Heat | Cumulus Podcast Network

4.41511762000
The Ben Shapiro Show
The Daily Wire

4.2155648
TENNIS.com Podcast
TENNIS.com Podcast/Tennis Channel Podcast Network

4.510879779
The Joe Budden Podcast
The Joe Budden Network

4.611699506
The Bulwark Podcast
The Bulwark

4.711530393
Matt and Shane's Secret Podcast
Matt McCusker & Shane Gillis

4.72577183
Smosh Reads Reddit Stories
Smosh

4.975261756
Small Town Murder
James Pietragallo, Jimmie Whisman

